GH treatment presented similar effects regarding ALT and sarcopenia reduction; however, it was associated with hepatomegaly, hyperinsulinemia, the reduction of serum levels of leptin and adiponectin and no significant steatosis reduction in histology assessment. Here, GH1 is linked to sarcopenia.